AHR and psoriasis: Of note, beyond AHR-binding activity, the efficacy might also involve changes in the skin microbiome, which could also be the case for tapinarof, another effective anti-inflammatory drug and AHR-ligand used against atopic dermatitis and psoriasis [132].